In this week's Nature, University of California, Berkeley scientists and others investigate a new CRISPR nuclease — dubbed CasX — that can edit the human genome with different functionality than Cas9 and Cas12a. CasX was isolated from groundwater microbes and is smaller than other CRISPR nucleases at fewer than 1,000 amino acids. The authors show that CasX can modify both human and E.